Personalised Estimation of the Arterial Input Function for Improved Pharmacokinetic Modelling of Colorectal Cancer Using dceMRI
dceMRI is becoming a key modality for tumour characterisation and monitoring of response to therapy, because of the ability to identify the underlying tumour physiology. Pharmacokinetic (PK) models relate the contrast enhancement seen in dceMRI to physiological parameters but require accurate measurement of the AIF, the time-dependant contrast concentration in blood plasma. In this study, a novel method is introduced that overcomes the challenges of direct AIF measurement, by automatically estimating the AIF from the tumour tissue. This approach was evaluated on synthetic data (10% noise) and achieved a relative error in K trans and k ep of 11.8 ±3.5% and 25.7 ±4.7 %, respectively, compared to 41 ±15 % and 60 ±32 % using a population model. The method improved the fit of the PK model to clinical colorectal cancer cases, was stable for independent regions in the tumour, and showed improved localisation of the PK parameters. This demonstrates that personalised AIF estimation can lead to more accurate PK modelling.
Keywordspharmacokinetic modelling arterial input function dceMRI
Unable to display preview. Download preview PDF.
- 2.Parker, G., Roberts, C., Macdonald, A., Buonaccorsi, G., Cheung, S., Buckley, D., Jackson, A., Watson, Y., Davies, K., Jayson, G.: Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn. Reson. Med. 56, 993–1000 (2006)CrossRefGoogle Scholar
- 3.Enescu, M., Bhushan, M., Hill, E.J., Franklin, J., Anderson, E.M., Sharma, R.A., Schnabel, J.A.: pCT derived arterial input function for improved pharmacokinetic analysis of longitudinal dceMRI for colorectal cancer. In: SPIE, p. 86690 (2013)Google Scholar
- 7.Tofts, P.S., Brix, G., Buckley, D.L., Evelhoch, J.L., Henderson, E., Knopp, M.V., Larsson, H.B.W., Lee, T.Y., Mayr, N.A., et al.: Parker: Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. Magn. Reson. Imaging 10, 223–232 (1999)CrossRefGoogle Scholar
- 8.Bradley, D.P., Tessier, J.L., Checkley, D., Kuribayashi, H., Waterton, J.C., Kendrew, J., Wedge, S.R.: Effects of AZD2171 and vandetanib (ZD6474, Zactima) on haemodynamic variables in an SW620 human colon tumour model: an investigation using dynamic contrast-enhanced MRI and the rapid clearance blood pool contrast agent, vol. 20, pp. 42–52 (2008)Google Scholar